Literature DB >> 16731738

Gene therapy for children with cystic fibrosis--who has the right to choose?

A Jaffé1, S A Prasad, V Larcher, S Hart.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16731738      PMCID： PMC2563368          DOI： 10.1136/jme.2005.012740

Source DB:  PubMed          Journal:  J Med Ethics        ISSN： 0306-6800            Impact factor:   2.903


× No keyword cloud information.
  23 in total

1.  The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium.

Authors:  C Kitson; B Angel; D Judd; S Rothery; N J Severs; A Dewar; L Huang; S C Wadsworth; S H Cheng; D M Geddes; E W Alton
Journal:  Gene Ther       Date:  1999-04       Impact factor: 5.250

Review 2.  Prospects for gene therapy in cystic fibrosis.

Authors:  A Jaffé; A Bush; D M Geddes; E W Alton
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

Review 3.  Recent developments in gene transfer: risk and ethics.

Authors:  Jonathan Kimmelman
Journal:  BMJ       Date:  2005-01-08

4.  Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution.

Authors:  Michael W Konstan; Pamela B Davis; Jeffrey S Wagener; Kathleen A Hilliard; Robert C Stern; Laura J H Milgram; Tomasz H Kowalczyk; Susannah L Hyatt; Tamara L Fink; Christopher R Gedeon; Sharon M Oette; Jennifer M Payne; Osman Muhammad; Assem G Ziady; Robert C Moen; Mark J Cooper
Journal:  Hum Gene Ther       Date:  2004-12       Impact factor: 5.695

5.  Guidelines for the ethical conduct of medical research involving children.

Authors: 
Journal:  Bull Med Ethics       Date:  1992 Jul-Aug

6.  Increasing response rates to postal questionnaires: a randomised trial of variations in design.

Authors:  Suezann Puffer; Jill Porthouse; Yvonne Birks; Veronica Morton; David Torgerson
Journal:  J Health Serv Res Policy       Date:  2004-10

7.  Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial.

Authors:  E W Alton; M Stern; R Farley; A Jaffe; S L Chadwick; J Phillips; J Davies; S N Smith; J Browning; M G Davies; M E Hodson; S R Durham; D Li; P K Jeffery; M Scallan; R Balfour; S J Eastman; S H Cheng; A E Smith; D Meeker; D M Geddes
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321

8.  Early pulmonary inflammation in infants with cystic fibrosis.

Authors:  T Z Khan; J S Wagener; T Bost; J Martinez; F J Accurso; D W Riches
Journal:  Am J Respir Crit Care Med       Date:  1995-04       Impact factor: 21.405

9.  Empirical examination of the ability of children to consent to clinical research.

Authors:  N Ondrusek; R Abramovitch; P Pencharz; G Koren
Journal:  J Med Ethics       Date:  1998-06       Impact factor: 2.903

Review 10.  Gene therapy for cystic fibrosis: an example for lung gene therapy.

Authors:  U Griesenbach; D M Geddes; E W F W Alton
Journal:  Gene Ther       Date:  2004-10       Impact factor: 5.250
View more
  1 in total

1.  Avatar acceptability: views from the Australian Cystic Fibrosis community on the use of personalised organoid technology to guide treatment decisions.

Authors:  Laura K Fawcett; Claire E Wakefield; Sheila Sivam; Peter G Middleton; Peter Wark; John Widger; Adam Jaffe; Shafagh A Waters
Journal:  ERJ Open Res       Date:  2021-01-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.